Dawnrays Pharma has made great efforts to develop system specific medicines, and the cardiovascular system is its main research direction as well as the medicine field it had built-up advantages.
Dawnrays Pharma has successfully developed brand anti-hypertensive drugs in "An" series of medicines. The drugs include Amlozen™, An Meiping, An Neixi, Armotan™ and An Liya.
Dawnrays Pharma had participated in the integrated medical project (Chinese Hypertension Intervention Efficacy Study, CHIEF Study) for the prevention and treatment of hypertension in 2007, the largest of its kind in China at the time, as the exclusive research and cooperation partner and designated supplier for drugs used in the research.

Armotan™ Generic name: Telmisartan Tablets
Trade Name: Armotan™
Generic name: Telmisartan Tablets
An Neixi Generic name: Losartan Potassium and Hydrochlorothiazide Tablets
Trade Name: An Neixi
Generic name: Losartan Potassium and Hydrochlorothiazide Tablets
G

苏公网安备 32050602010200号